Daehan New Pharm Co Ltd banner
D

Daehan New Pharm Co Ltd
KOSDAQ:054670

Watchlist Manager
Daehan New Pharm Co Ltd
KOSDAQ:054670
Watchlist
Price: 6 900 KRW 0.58% Market Closed
Market Cap: ₩99B

Profitability Summary

Daehan New Pharm Co Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Daehan New Pharm Co Ltd

Margins Comparison
Daehan New Pharm Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
KR
Daehan New Pharm Co Ltd
KOSDAQ:054670
96.8B KRW
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
993.5B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
590.8B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
298B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
239.4B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
246.7B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
307.1B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.9B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
123.1B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Daehan New Pharm Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
KR
Daehan New Pharm Co Ltd
KOSDAQ:054670
96.8B KRW
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
993.5B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
590.8B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
298B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
239.4B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
246.7B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
307.1B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.9B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
123.1B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Daehan New Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate